| Literature DB >> 31209406 |
Marina Cella1, Ramya Gamini2, Cristiane Sécca1, Patrick L Collins1,3, Shanrong Zhao2, Vincent Peng1, Michelle L Robinette1,4, Jorge Schettini2, Konstantin Zaitsev1,5, William Gordon2,6, Jennifer K Bando1, Kentaro Yomogida1, Victor Cortez1,7, Catrina Fronick8, Robert Fulton8, Lih-Ling Lin2,9, Susan Gilfillan1, Richard A Flavell10,11, Liang Shan12, Maxim N Artyomov1, Michael Bowman2,9, Eugene M Oltz1,3, Scott A Jelinsky13, Marco Colonna14.
Abstract
Innate lymphoid cells (ILCs) are tissue-resident lymphocytes categorized on the basis of their core regulatory programs and the expression of signature cytokines. Human ILC3s that produce the cytokine interleukin-22 convert into ILC1-like cells that produce interferon-γ in vitro, but whether this conversion occurs in vivo remains unclear. In the present study we found that ILC3s and ILC1s in human tonsils represented the ends of a spectrum that included additional discrete subsets. RNA velocity analysis identified an intermediate ILC3-ILC1 cluster, which had strong directionality toward ILC1s. In humanized mice, the acquisition of ILC1 features by ILC3s showed tissue dependency. Chromatin studies indicated that the transcription factors Aiolos and T-bet cooperated to repress regulatory elements active in ILC3s. A transitional ILC3-ILC1 population was also detected in the human intestine. We conclude that ILC3s undergo conversion into ILC1-like cells in human tissues in vivo, and that tissue factors and Aiolos were required for this process.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31209406 PMCID: PMC6685551 DOI: 10.1038/s41590-019-0425-y
Source DB: PubMed Journal: Nat Immunol ISSN: 1529-2908 Impact factor: 25.606